WebBiodexa Pharmaceuticals plc American Depositary Shs (BDRX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. WebDec 13, 2024 · The combination of Bioasis and Midatech will create a multi-asset rare and orphan disease company that will be renamed Biodexa Pharmaceuticals PLC …
About - Biodexa Pharmaceuticals - Midatech Pharma
WebBiodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as … WebApr 11, 2024 · Biodexa Pharmaceuticals ’s (BDRX) 100-Day exponential moving average is 3.37, while Biodexa Pharmaceuticals ’s (BDRX) share price is $0.262, making it a Sell. Biodexa Pharmaceuticals ’s (BDRX) stock price is $0.262 and Biodexa Pharmaceuticals ’s (BDRX) 50-day simple moving average is 1.83, creating a Sell signal. chevery
Biodexa Pharmaceuticals PLC Announces Exercise of Warrants …
WebApr 12, 2024 · Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in the United Kingdom, rest … WebApr 4, 2024 · Biodexa Pharmaceuticals PLC (dual listed on AIM:BDRX; and NASDAQ:BDRX) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The Company combines approved and development medications with its proprietary and innovative drug delivery technologies … WebApr 11, 2016 · Biodexa Pharmaceuticals Plc. News. Summary BDRX GB00BNGF1L75. BIODEXA PHARMACEUTICALS PLC (BDRX) Add to my list. Report. Delayed London Stock Exchange - 08:38:35 2024-04-11 am EDT 5.120: GBX -6.91%: 04/06: Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants and Issue of … cheves boyce